|
|
||||||||
J. S. Lymn and A. D. Hughes are in the Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, QEQM Wing, St. Mary's Hospital, Paddington, London W2 1NY, England.
The function of differentiated vascular smooth muscle cells (VSMC) in vivo is the regulation of contractility. Following injury or disease, however, VSMC lose their contractile function and take on a synthetic, proliferative phenotype. This dedifferentiation is generally accompanied by a change in the expression profile of phospholipase C isoforms.
This article has been cited by other articles:
![]() |
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation Cardiovasc Res, August 1, 2005; 67(2): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Murthy, H. Zhou, J. Huang, and S. N. Pentyala Activation of PLC-{delta}1 by Gi/o-coupled receptor agonists Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1679 - C1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Abdel-Latif Cross Talk Between Cyclic Nucleotides and Polyphosphoinositide Hydrolysis, Protein Kinases, and Contraction in Smooth Muscle Experimental Biology and Medicine, March 1, 2001; 226(3): 153 - 163. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |